Melanie Schorr Haines, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anorexia Nervosa | 14 | 2022 | 1286 | 2.590 |
Why?
|
Bone Density | 13 | 2023 | 3468 | 1.350 |
Why?
|
Body Composition | 11 | 2022 | 2401 | 1.270 |
Why?
|
Absorptiometry, Photon | 12 | 2023 | 1725 | 0.910 |
Why?
|
Paranoid Disorders | 1 | 2023 | 60 | 0.880 |
Why?
|
Insulin-Like Growth Factor I | 7 | 2023 | 2015 | 0.880 |
Why?
|
Sarcopenia | 2 | 2022 | 368 | 0.830 |
Why?
|
Hypokalemia | 1 | 2023 | 153 | 0.810 |
Why?
|
Overweight | 8 | 2023 | 2371 | 0.770 |
Why?
|
Leptin | 2 | 2023 | 1599 | 0.680 |
Why?
|
Acromegaly | 3 | 2022 | 346 | 0.570 |
Why?
|
Obesity | 10 | 2023 | 12745 | 0.550 |
Why?
|
Human Growth Hormone | 4 | 2022 | 683 | 0.540 |
Why?
|
Bone Density Conservation Agents | 1 | 2022 | 773 | 0.520 |
Why?
|
Spine | 3 | 2017 | 1144 | 0.510 |
Why?
|
Pregnanolone | 2 | 2019 | 62 | 0.470 |
Why?
|
Thinness | 2 | 2017 | 480 | 0.460 |
Why?
|
Insulin Resistance | 3 | 2020 | 3864 | 0.430 |
Why?
|
Hydrocortisone | 3 | 2022 | 1826 | 0.380 |
Why?
|
Cross-Sectional Studies | 18 | 2023 | 25043 | 0.370 |
Why?
|
Adipose Tissue | 4 | 2020 | 3279 | 0.370 |
Why?
|
Calcium | 1 | 2023 | 5756 | 0.360 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 11725 | 0.360 |
Why?
|
Oxytocin | 2 | 2020 | 394 | 0.360 |
Why?
|
Muscle, Skeletal | 3 | 2022 | 4931 | 0.350 |
Why?
|
Bone Diseases, Metabolic | 2 | 2019 | 417 | 0.330 |
Why?
|
Estrogens | 2 | 2021 | 1566 | 0.330 |
Why?
|
Finite Element Analysis | 2 | 2019 | 431 | 0.330 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2019 | 188 | 0.320 |
Why?
|
Androstane-3,17-diol | 1 | 2017 | 19 | 0.320 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2018 | 76 | 0.310 |
Why?
|
Lipid Metabolism Disorders | 1 | 2017 | 19 | 0.310 |
Why?
|
Adrenal Insufficiency | 1 | 2019 | 184 | 0.300 |
Why?
|
Pelvic Bones | 2 | 2020 | 265 | 0.300 |
Why?
|
Bone and Bones | 3 | 2022 | 2575 | 0.280 |
Why?
|
Thyroid Nodule | 1 | 2013 | 750 | 0.280 |
Why?
|
Intra-Abdominal Fat | 3 | 2017 | 591 | 0.280 |
Why?
|
Young Adult | 18 | 2022 | 56430 | 0.280 |
Why?
|
Amenorrhea | 2 | 2017 | 485 | 0.270 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 424 | 0.270 |
Why?
|
Hip | 1 | 2017 | 257 | 0.270 |
Why?
|
Subcutaneous Fat | 2 | 2017 | 391 | 0.260 |
Why?
|
Pituitary-Adrenal System | 2 | 2016 | 553 | 0.260 |
Why?
|
Estradiol | 2 | 2023 | 2020 | 0.250 |
Why?
|
Affective Symptoms | 1 | 2017 | 407 | 0.250 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2016 | 703 | 0.250 |
Why?
|
Endocrine System Diseases | 1 | 2016 | 248 | 0.240 |
Why?
|
Nutrition Surveys | 2 | 2022 | 1660 | 0.240 |
Why?
|
Lumbar Vertebrae | 2 | 2023 | 1848 | 0.220 |
Why?
|
Bone Remodeling | 2 | 2022 | 575 | 0.200 |
Why?
|
Liver Cirrhosis | 2 | 2022 | 1863 | 0.200 |
Why?
|
Body Weight | 3 | 2017 | 4669 | 0.200 |
Why?
|
Tibia | 1 | 2017 | 1077 | 0.200 |
Why?
|
Pituitary Apoplexy | 1 | 2021 | 30 | 0.200 |
Why?
|
Adult | 26 | 2023 | 214055 | 0.190 |
Why?
|
Female | 29 | 2023 | 380194 | 0.190 |
Why?
|
Body Fat Distribution | 1 | 2022 | 244 | 0.190 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2020 | 19 | 0.180 |
Why?
|
Progesterone | 2 | 2019 | 776 | 0.180 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 238 | 0.180 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2016 | 1953 | 0.170 |
Why?
|
Middle Aged | 20 | 2023 | 213383 | 0.170 |
Why?
|
Luteal Phase | 1 | 2019 | 147 | 0.170 |
Why?
|
Follicular Phase | 1 | 2019 | 153 | 0.170 |
Why?
|
Body Mass Index | 4 | 2022 | 12720 | 0.170 |
Why?
|
Spinal Fractures | 1 | 2015 | 696 | 0.160 |
Why?
|
Vasopressins | 1 | 2020 | 370 | 0.160 |
Why?
|
Hypopituitarism | 1 | 2020 | 254 | 0.150 |
Why?
|
Sex Characteristics | 1 | 2018 | 2585 | 0.150 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9438 | 0.150 |
Why?
|
Growth Hormone | 3 | 2023 | 705 | 0.150 |
Why?
|
Humans | 35 | 2023 | 744343 | 0.150 |
Why?
|
Testosterone | 2 | 2023 | 2420 | 0.140 |
Why?
|
Critical Illness | 1 | 2019 | 2670 | 0.140 |
Why?
|
Male | 18 | 2023 | 350118 | 0.140 |
Why?
|
Carrier Proteins | 1 | 2019 | 5021 | 0.140 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.130 |
Why?
|
Anxiety | 2 | 2017 | 4297 | 0.130 |
Why?
|
Cushing Syndrome | 1 | 2016 | 249 | 0.130 |
Why?
|
Estrogen Replacement Therapy | 1 | 2021 | 1203 | 0.120 |
Why?
|
Weight-Bearing | 2 | 2017 | 515 | 0.120 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2013 | 45 | 0.120 |
Why?
|
Depressive Disorder | 1 | 2016 | 3748 | 0.110 |
Why?
|
Somatostatin | 2 | 2020 | 459 | 0.110 |
Why?
|
Pituitary Neoplasms | 1 | 2021 | 1345 | 0.110 |
Why?
|
Blood Glucose | 2 | 2022 | 6256 | 0.100 |
Why?
|
Menopause | 1 | 2019 | 1626 | 0.100 |
Why?
|
Recombinant Proteins | 1 | 2021 | 6622 | 0.100 |
Why?
|
Prevalence | 3 | 2022 | 15226 | 0.100 |
Why?
|
Adolescent | 10 | 2021 | 85781 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4397 | 0.090 |
Why?
|
Adenoma | 1 | 2021 | 2174 | 0.090 |
Why?
|
Pituitary-Adrenal Function Tests | 1 | 2019 | 31 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2214 | 0.090 |
Why?
|
Globulins | 1 | 2019 | 19 | 0.090 |
Why?
|
Models, Biological | 1 | 2015 | 9583 | 0.080 |
Why?
|
Biopsy, Fine-Needle | 1 | 2013 | 1094 | 0.080 |
Why?
|
Ergolines | 1 | 2017 | 61 | 0.080 |
Why?
|
Lipodystrophy | 1 | 2017 | 147 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4253 | 0.070 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 976 | 0.070 |
Why?
|
Peptides, Cyclic | 1 | 2017 | 400 | 0.060 |
Why?
|
Risk Assessment | 1 | 2016 | 23338 | 0.060 |
Why?
|
Adipokines | 1 | 2016 | 319 | 0.060 |
Why?
|
Hormone Replacement Therapy | 1 | 2019 | 745 | 0.060 |
Why?
|
Anthropometry | 1 | 2018 | 1350 | 0.060 |
Why?
|
Gonadal Steroid Hormones | 1 | 2017 | 712 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1157 | 0.060 |
Why?
|
Prednisone | 1 | 2017 | 1574 | 0.050 |
Why?
|
Prospective Studies | 2 | 2022 | 53288 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14722 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15165 | 0.050 |
Why?
|
Prognosis | 3 | 2018 | 29063 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39050 | 0.050 |
Why?
|
Premenopause | 1 | 2016 | 1033 | 0.050 |
Why?
|
Administration, Oral | 1 | 2019 | 3913 | 0.050 |
Why?
|
Exercise Test | 1 | 2018 | 2074 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20129 | 0.050 |
Why?
|
Liver | 2 | 2023 | 7474 | 0.050 |
Why?
|
Receptors, Somatotropin | 1 | 2020 | 76 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1889 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2017 | 21746 | 0.040 |
Why?
|
Causality | 1 | 2016 | 1275 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2021 | 711 | 0.040 |
Why?
|
Aged | 7 | 2022 | 163280 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2023 | 12026 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12959 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 8428 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6038 | 0.040 |
Why?
|
Calcium, Dietary | 1 | 2019 | 526 | 0.030 |
Why?
|
Adrenal Gland Diseases | 1 | 2016 | 138 | 0.030 |
Why?
|
Pituitary Diseases | 1 | 2016 | 141 | 0.030 |
Why?
|
Health Status | 1 | 2018 | 4034 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2021 | 1205 | 0.030 |
Why?
|
United States | 1 | 2022 | 69872 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 77449 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 547 | 0.030 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.030 |
Why?
|
Eating | 1 | 2019 | 1536 | 0.030 |
Why?
|
Weight Gain | 1 | 2022 | 2292 | 0.030 |
Why?
|
Comorbidity | 1 | 2016 | 10388 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3305 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6489 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 12804 | 0.020 |
Why?
|
Risk Factors | 2 | 2018 | 72290 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15540 | 0.020 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1343 | 0.020 |
Why?
|
Depression | 1 | 2017 | 7766 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.020 |
Why?
|
Cohort Studies | 1 | 2019 | 40561 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3223 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13989 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2021 | 63114 | 0.010 |
Why?
|